pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
Drilling Resumes on Berrigan Zinc, Gold, Silver Property under Option from Chibougamau Independent Mines
Angkor Resources Undertakes IP Survey Over Copper/Iron Skarn Adjacent to Canada Wall Copper Porphyry Target, Andong Meas License, Cambodia
American Uranium Advances Wyoming ISR Development with Resource Growth and Confidence Upgrade at Lo Herma
